Since 1995, we have tirelessly researched innovative and breakthrough methods to treat some of the most pervasive and deadly diseases afflicting the world's population. Our goal is to bring these methods, in the form of one powerful and multi-faceted drug, Hypoestoxide, into the hands of those who need it most.  


At IMI, we are addressing global unmet medical needs by the development of novel pharmaceutical, nutraceutical, and cosmetic agents from natural bio-resources that treat and prevent a variety of human diseases.

IMI is uniquely poised to radically alter the global healthcare landscape by delivering orally bio-available, more effective, and non-toxic anti-inflammatory, anti-cancer, anti-parasitic, anti-hyperlipidemia, anti-Parkinson's disease, and anti-skin aging therapeutics.